These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1098 related items for PubMed ID: 27208776

  • 1. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
    He Q, Sha S, Sun L, Zhang J, Dong M.
    Biochem Biophys Res Commun; 2016 Aug 05; 476(4):196-203. PubMed ID: 27208776
    [Abstract] [Full Text] [Related]

  • 2. LRG ameliorates steatohepatitis by activating the AMPK/mTOR/SREBP1 signaling pathway in C57BL/6J mice fed a high‑fat diet.
    Hao T, Chen H, Wu S, Tian H.
    Mol Med Rep; 2019 Jul 05; 20(1):701-708. PubMed ID: 31180545
    [Abstract] [Full Text] [Related]

  • 3. Acetaminophen aggravates fat accumulation in NAFLD by inhibiting autophagy via the AMPK/mTOR pathway.
    Shi C, Xue W, Han B, Yang F, Yin Y, Hu C.
    Eur J Pharmacol; 2019 May 05; 850():15-22. PubMed ID: 30753863
    [Abstract] [Full Text] [Related]

  • 4. [Liraglutide alleviates lipotoxic liver cell damage and promotes autophagy to improve non-alcoholic fatty liver].
    Zhang Q, Liu Q, Niu CY.
    Zhonghua Gan Zang Bing Za Zhi; 2021 May 20; 29(5):456-461. PubMed ID: 34107584
    [Abstract] [Full Text] [Related]

  • 5. The preventive effect of liraglutide on the lipotoxic liver injury via increasing autophagy.
    He Y, Ao N, Yang J, Wang X, Jin S, Du J.
    Ann Hepatol; 2020 May 20; 19(1):44-52. PubMed ID: 31787541
    [Abstract] [Full Text] [Related]

  • 6. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J, Du H, Shen M, Zhao Z, Ye X.
    J Immunol Res; 2020 May 20; 2020():3413186. PubMed ID: 32884949
    [Abstract] [Full Text] [Related]

  • 7. Neuregulin 4 alleviates hepatic steatosis via activating AMPK/mTOR-mediated autophagy in aged mice fed a high fat diet.
    Zhu B, Mei W, Jiao T, Yang S, Xu X, Yu H, Ding Y, Guo S, Meng B, Zhao L, He M, Dong K, Guo H, Guo X, Zhang H, Dang R, Xiang G, Wen N.
    Eur J Pharmacol; 2020 Oct 05; 884():173350. PubMed ID: 32726654
    [Abstract] [Full Text] [Related]

  • 8. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
    Gao H, Zeng Z, Zhang H, Zhou X, Guan L, Deng W, Xu L.
    Biol Pharm Bull; 2015 Oct 05; 38(5):694-702. PubMed ID: 25947915
    [Abstract] [Full Text] [Related]

  • 9. Effects of the new thiazolidine derivative LPSF/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD).
    Araújo S, Soares E Silva A, Gomes F, Ribeiro E, Oliveira W, Oliveira A, Lima I, Lima MDC, Pitta I, Peixoto C.
    Eur J Pharmacol; 2016 Oct 05; 788():306-314. PubMed ID: 27349145
    [Abstract] [Full Text] [Related]

  • 10. Liraglutide promotes autophagy by regulating the AMPK/mTOR pathway in a rat remnant kidney model of chronic renal failure.
    Xue L, Pan Z, Yin Q, Zhang P, Zhang J, Qi W.
    Int Urol Nephrol; 2019 Dec 05; 51(12):2305-2313. PubMed ID: 31531806
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
    Liou CJ, Wei CH, Chen YL, Cheng CY, Wang CL, Huang WC.
    Cell Physiol Biochem; 2018 Dec 05; 49(5):1870-1884. PubMed ID: 30235452
    [Abstract] [Full Text] [Related]

  • 13. Vine tea total flavonoids activate the AMPK/mTOR pathway to amelioration hepatic steatosis in mice fed a high-fat diet.
    Wang C, Yang F, Zeng W, Chen X, Qiu Z, Wang Q, Meng Y, Zheng G, Hu J.
    J Food Sci; 2024 May 05; 89(5):3019-3036. PubMed ID: 38517018
    [Abstract] [Full Text] [Related]

  • 14. Exogenous galanin alleviates hepatic steatosis by promoting autophagy via the AMPK-mTOR pathway.
    Zhu S, Wang S, Luo T.
    Arch Biochem Biophys; 2023 Aug 05; 744():109689. PubMed ID: 37429535
    [Abstract] [Full Text] [Related]

  • 15. ERK-dependent mTOR pathway is involved in berberine-induced autophagy in hepatic steatosis.
    He Q, Mei D, Sha S, Fan S, Wang L, Dong M.
    J Mol Endocrinol; 2016 Nov 05; 57(4):251-260. PubMed ID: 27658958
    [Abstract] [Full Text] [Related]

  • 16. Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK/mTOR signaling pathway.
    Yan LS, Zhang SF, Luo G, Cheng BC, Zhang C, Wang YW, Qiu XY, Zhou XH, Wang QG, Song XL, Pan SY, Zhang Y.
    Metabolism; 2022 Jun 05; 131():155200. PubMed ID: 35405150
    [Abstract] [Full Text] [Related]

  • 17. Ginsenoside Rb2 Alleviates Hepatic Lipid Accumulation by Restoring Autophagy via Induction of Sirt1 and Activation of AMPK.
    Huang Q, Wang T, Yang L, Wang HY.
    Int J Mol Sci; 2017 May 19; 18(5):. PubMed ID: 28534819
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of ghrelin o-acyltransferase attenuated lipotoxicity by inducing autophagy via AMPK-mTOR pathway.
    Zhang S, Mao Y, Fan X.
    Drug Des Devel Ther; 2018 May 19; 12():873-885. PubMed ID: 29713145
    [Abstract] [Full Text] [Related]

  • 19. Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway.
    Han X, Ding C, Zhang G, Pan R, Liu Y, Huang N, Hou N, Han F, Xu W, Sun X.
    Biochem Biophys Res Commun; 2020 May 14; 525(4):895-901. PubMed ID: 32171530
    [Abstract] [Full Text] [Related]

  • 20. Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway.
    Zhang Y, Chen ML, Zhou Y, Yi L, Gao YX, Ran L, Chen SH, Zhang T, Zhou X, Zou D, Wu B, Wu Y, Chang H, Zhu JD, Zhang QY, Mi MT.
    Mol Nutr Food Res; 2015 Aug 14; 59(8):1443-57. PubMed ID: 25943029
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 55.